Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus

Infection and Immunity

Volumn 66, Issue 12, 1998, Pages 5999-6003

  Roilides, Emmanuel ^a,b   Dimitriadou Georgiadou, Anastasia ^a   Sein, Tin ^b   Kadiltsoglou, Isaac ^a   Walsh, Thomas J ^b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INCUBATION TIME; INFECTION SENSITIVITY; LUNG ALVEOLUS MACROPHAGE; MONONUCLEAR PHAGOCYTE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RABBIT; STATISTICAL ANALYSIS;

EID: 0031741636     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.12.5999-6003.1998     Document Type: Article

References (46)

1. Abraham, E., M. P. Glauser, T. Butler, J. Garbino, D. Gelmont, P. F. Laterre, K. Kudsk, H. A. Bruining, C. Otto, E. Tobin, C. Zwingelstein, W. Lesslauer, and A. Leighton. 1997. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277:1531-1538.
2. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725-1731.
3. Atkinson, Y. H., W. A. Marasco, A. F. Lopez, and A. M. Vadas. 1988. Recombinant human tumor necrosis factor alpha. Regulation of N-formyl methionyl leucyl phenylalanine receptor affinity and function on human neutrophils. J. Clin. Invest. 81:759-765.
4. Beck-Sague, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
5. Beutler, B., and A. Cerami. 1986. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320:584-588.
6. Beutler, B., I. W. Milsark, and A. Cerami. 1985. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J. Immunol. 135: 3972-3977.
7. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 97(Suppl.):77-89.
8. Cenci, E., S. Perito, K.-H. Enssle, P. Mosci, J.-P. Latge, L. Romani, and F. Bistoni. 1997. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect. Immun. 65:564-570.
9. Cohen, J., and J. Carlet. 1996. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit. Care Med. 24:1431-1440.
10. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12: 1147-1201.
11. Diamond, R. D., R. Krzesicki, B. Epstein, and W. Jao. 1978. Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis. Am. J. Pathol. 91:313-328.
12. Diamond, R. D., R. Krzesicki, and W. Jao. 1978. Damage to pseudohyphal form of C. albicans by neutrophils in the absence of serum in vitro. J. Clin. Invest. 61:349-359.
13. Diamond, R. D., C. A. Lyman, and D. R. Wysong. 1991. Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J. Clin. Invest. 87:711-720.
14. Djeu, J. Y., D. K. Blanchard, D. Halkias, and H. Friedman. 1986. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J. Immunol. 137: 2980-2984.
15. Ferrante, A. 1989. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun. 57:2115-2122.
16. Ferrante, A., M. Nandoskar, A. Walz, D. H. B. Goh, and I. C. Kowanko. 1988. Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int. Arch. Appl. Immunol. 86:82-91.
17. Gamble, J. R., J. M. Harlan, S. J. Klebanoff, and N. A. Vadas. 1985. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Inflammation/tumor resection/ adherence proteins/blood vessels. Proc. Natl. Acad. Sci. USA 82:8667-8671.
18. Glimaker, M., P. Kragsbjerg, M. Forsgren, and P. Olcen. 1993. Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis. J. Infect. Dis. 167:882-889.
19. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital. J. Infect. 33:23-32.
20. Klebanoff, S. J., M. A. Vadas, J. M. Harlan, L. H. Sparks, J. R. Gamble, J. M. Agosti, and A. M. Waltersdorph. 1986. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136:4220-4225.
21. Levitz, S., M. E. Selsted, T. Ganz, R. I. Lehrer, and R. D. Diamond. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis. 154:483-489.
22. Levitz, S. M., and R. D. Diamond. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 152:938-945.
23. Levitz, S. M., A. Tabuni, S.-H. Nong, and D. T. Golenbock. 1996. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun. 64:945-951.
24. Liles, W. C., J. E. Huang, J. A. van Bunk, R. A. Bowden, and D. C. Dale. 1997. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J. Infect. Dis. 175:1012-1015.
25. Louie, A, A. L. Baltch, R. P. Smith, M. A. Franke, W. J. Ritz, J. K. Singh, and M. A. Gordon. 1994. Tumor necrosis factor alpha has a protective role in a marine model of systemic candidiasis. Infect. Immun. 62:2761-2772.
26. Nagai, H., J. Guo, H. Choi, and V. Kurup. 1995. Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis. J. Infect. Dis. 172: 1554-1560.
27. Netea, M. G., W. L. Blok, B. J. Kullberg, M. Bemelmans, M. T. Vogels, W. A. Buurman, and J. W. van der Meer. 1995. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J. Infect. Dis. 171: 393-399.
28. Perussia, B., M. Kobayashi, M. E. Rossi, I. Anegon, and G. Trinchieri. 1987. Immune interferon enhances properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 138:765-774.
29. Rex, J. H., J. E. Bennett, J. I. Gallin, H. L. Malech, E. S. Decarlo, and D. A. Melnick. 1991. In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J. Infect. Dis. 163:849-852.
30. Riche F., Y. Panis, M. J. Laisne, C. Briard, B. Cholley, O. Bernard-Poenaru, A. M. Graulet, J. Gueris, and P. Valleur. 1996. High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery 120:801-807.
31. Roilides, E., A. Dimitriadou, I. Kadiltsoglou, T. Sein, J. Karpouzas, P. A. Pizzo, and T. J. Walsh. 1997. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Immunol. 158:322-329.
32. Roilides, E., and P. A. Pizzo. 1992. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin. Infect. Dis. 15:508-524.
33. Roilides, E., T. Sein, A. Holmes, C. Blake, P. A. Pizzo, and T. J. Walsh. 1995. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 172: 1028-1034.
34. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Granulocyte colony-stimulating factor and interferon-γ enhance the oxidative responses and the damage caused by human neutrophils to Aspergillus fumigatus hyphae in vitro. Infect. Immun. 61:1185-1193.
35. Roilides, E., T. J. Walsh, and P. A. Pizzo. 1993. Clinical use of cytokines during fungal infections, p. 90-97. In R. van Furth (ed.), Hemopoietic growth factors and mononuclear phagocytes. S. Karger, Basel, Switzerland.
36. Roilides, E., T. J. Walsh, P. A. Pizzo, and M. Rubin. 1991. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163:579-583.
37. Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69: 617-631.
38. Seow, W. K., Y. H. Thong, and A. Ferrante. 1987. Macrophage-neutrophil interactions: contrasting effects of the monokines interleukin-1 and tumor necrosis factor (cachectin) on human neutrophil adherence. Immunology. 62:357-361.
39. Shalaby, M. R., B. B. Aggarwal, E. Rinderknecht, L. P. Svendersky, B. S. Finkle, and M. A. Palladino. 1985. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factor. J. Immunol. 135:2069-2073.
40. Shalaby, M. R., M. A. Palladino, S. E. Hirabayashi, T. E. Eessalu, G. D. Lewis, H. M. Shepard, and B. Aggarwal. 1987. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J. Leukoc. Biol. 41:196-204.
41. Smith, J. G., D. M. Magee, D. M. Williams, and J. R. Graybill. 1990 Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum. J. Infect. Dis. 162:1349-1353.
42. Steinshamn, S., M. H. Bemelmans, L. J. van Tits, K. Bergh, W. A. Buurman, and A. Waage. 1996. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J. Immunol. 157:2155-2159.
43. Urban, J. L., H. M. Shepard, J. L. Rothstein, and B. J. Sugarman. 1986. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc. Natl. Acad. Sci. USA 83:5233-5237.
44. van Furth, A. M., E. M. Segmonsbergen, J. A. Langermans, P. H. Groeneveld, C. E. de Bel, and R. van Furth. 1995. High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin. Infect. Dis. 21:220-222.
45. Waldorf, A. R., S. Levitz, and R. D. Diamond. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis. 150:752-760.
46. Walsh, T. J. 1990. Invasive aspergillosis in patients with neoplastic diseases. Semin. Resp. Infect. 5:111-122.